MedTrace Logo

Myriad™ Augmented Soft Tissue Reconstruction Registry

NCT05243966 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2026-02-19

No results posted yet for this study

Summary

This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll participants who are undergoing a surgical procedure, where the attending physician will use Myriad™ as part of the surgical intervention.

Conditions

  • Abdominal Wound Dehiscence
  • Necrotizing Soft Tissue Infection
  • Lower Extremity Wound
  • Pilonidal Sinus
  • Anal Fistula
  • Hidradenitis Suppurativa
  • Pressure Injury

Interventions

DEVICE

Myriad Matrix™ and Myriad Morcells™

Ovine forestomach matrix sheet graft and morselized extracellular matrix

Sponsors & Collaborators

  • Aroa Biosurgery Limited

    lead INDUSTRY

Principal Investigators

  • Tracee Short, MD · Short Consulting Group, LLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-10
Primary Completion
2028-01-31
Completion
2029-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05243966 on ClinicalTrials.gov